Inhibition of p63 Transcriptional Activity by p14ARF: Functional and Physical Link between Human ARF Tumor Suppressor and a Member of the p53 Family
Open Access
- 1 October 2004
- journal article
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 24 (19) , 8529-8540
- https://doi.org/10.1128/mcb.24.19.8529-8540.2004
Abstract
The ARF/MDM2/p53 pathway is a principal defense mechanism to protect the organism from uncontrolled effects of deregulated oncogenes. Oncogenes activate ARF, which interacts with and inhibits the ubiquitin ligase MDM2, resulting in p53 stabilization and activation. Once stabilized and activated, p53 can either induce or repress a wide array of different gene targets, which in turn can regulate cell cycle, DNA repair, and a number of apoptosis-related genes. Here we show that, unlike p53, p63, a member of the p53 family, directly interacts with p14ARF. Through this interaction ARF inhibits p63-mediated transactivation and transrepression. In p63-transfected cells, ARF, which normally localizes into nucleoli, accumulates in the nucleoplasm. Based on these observations, we suggest that stimuli inducing p14ARF expression can, at the same time, activate p53 and impair p63 transcriptional activity, altering the pattern of p53 target gene expression. Here we show, for the first time, a physical and functional link between the p14ARF tumor suppressor protein and p63, a member of the p53 family.Keywords
This publication has 48 references indexed in Scilit:
- Functional and Physical Interaction of the Human ARF Tumor Suppressor with Tat-binding Protein-1Journal of Biological Chemistry, 2004
- Differential Regulation of E2F1, DP1, and the E2F1/DP1 Complex by ARFMolecular and Cellular Biology, 2002
- p63 and p73 are required for p53-dependent apoptosis in response to DNA damageNature, 2002
- Mutations in the p53 homolog p63: allele-specific developmental syndromes in humansTrends in Molecular Medicine, 2002
- Transcriptional Regulation of the Human Tumor Suppressor p14ARF by E2F1, E2F2, E2F3, and Sp1-like FactorsBiochemical and Biophysical Research Communications, 2002
- Switch from p53 to MDM2 as differentiating human keratinocytes lose their proliferative potential and increase in cellular sizeOncogene, 2000
- Immunolocalization of Human p14ARF to the Granular Component of the Interphase NucleolusExperimental Cell Research, 2000
- Association of p19ARF with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53The EMBO Journal, 1999
- Regulation of p53 stability by Mdm2Nature, 1997
- Mdm2 promotes the rapid degradation of p53Nature, 1997